The role of overweight and obesity in selected gynecological malignancies
- PMID: 29693868
The role of overweight and obesity in selected gynecological malignancies
Abstract
A review of literature data related to the effects of overweight and obesity on the development and course of selected gynecological malignancies: endometrial, breast and ovarian cancer is presented. Three hypotheses are included in an attempt to explain this rela- tionship: the adipokinine hypothesis, a hypothesis involving the effects of excessive estrogen levels, and the insulin hypothesis.
Similar articles
-
The polycystic ovary syndrome and gynecological cancer risk.Gynecol Endocrinol. 2020 Apr;36(4):289-293. doi: 10.1080/09513590.2020.1730794. Epub 2020 Feb 27. Gynecol Endocrinol. 2020. PMID: 32103691 Review.
-
Gynecological malignancies and obesity.Best Pract Res Clin Obstet Gynaecol. 2023 Jun;88:102337. doi: 10.1016/j.bpobgyn.2023.102337. Epub 2023 Apr 8. Best Pract Res Clin Obstet Gynaecol. 2023. PMID: 37117071 Review.
-
Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.Obstet Gynecol Clin North Am. 1994 Jun;21(2):245-70. Obstet Gynecol Clin North Am. 1994. PMID: 7936544 Review.
-
Diet and environmental carcinogenesis in breast/gynaecological cancers.Curr Opin Obstet Gynecol. 2002 Feb;14(1):13-8. doi: 10.1097/00001703-200202000-00003. Curr Opin Obstet Gynecol. 2002. PMID: 11801871 Review.
-
Is endometriosis a preneoplastic condition?Womens Health (Lond). 2015 Aug;11(5):701-3. doi: 10.2217/whe.15.57. Epub 2015 Sep 21. Womens Health (Lond). 2015. PMID: 26389731 Review. No abstract available.
Cited by
-
Pediatric and adult obesity concerns in female health: a Mendelian randomization study.Endocrine. 2022 Feb;75(2):400-408. doi: 10.1007/s12020-021-02867-y. Epub 2021 Sep 20. Endocrine. 2022. PMID: 34542801
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical